Form SEC STAFF ACTION Rastegar Income Fund
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hyperliquid Strategies raises buyback program to $100 million
- Perspective Therapeutics reports Phase 1/2a trial data for NET drug
- Vertex's povetacicept hits key endpoints in Phase 3 kidney disease trial
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share